John Trizzino - Aug 19, 2023 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
EVP, CCO and CBO
Signature
/s/ John A. Herrmann III, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Aug 19, 2023
Transactions value $
-$2,263
Form type
4
Date filed
8/22/2023, 04:47 PM
Previous filing
Jun 27, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise +655 +6.9% 10.1K Aug 19, 2023 Direct F1
transaction NVAX Common Stock Tax liability -$2.26K -317 -3.12% $7.14 9.83K Aug 19, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -655 -50% $0.00 655 Aug 19, 2023 Common Stock 655 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2 The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 19, 2021 grant date, in each case subject to continued employment through such vesting date.